Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021

Alexander Shivarev, Anastasia Phillips, Sam Brophy-Williams, Tim Ford, Peter Richmond, Paul Effler, Andrew McLean-Tooke

Research output: Contribution to journalArticlepeer-review

Abstract

Within the first 4 months of the Western Australian COVID-19 immunisation programme, 49 suspected anaphylaxis cases were reported to the vaccine safety surveillance system. Twelve reports met Brighton Collaboration case definition, corresponding to rates of 15.9 and 17.7 per million doses of Vaxzevria and Comirnaty administered respectively.

Original languageEnglish
Pages (from-to)275-279
Number of pages5
JournalInternal Medicine Journal
Volume53
Issue number2
DOIs
Publication statusPublished - Feb 2023

Fingerprint

Dive into the research topics of 'Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021'. Together they form a unique fingerprint.

Cite this